|
|
|
|
Comparison |
name |
Catalog # |
Specificity/Activity |
Type |
Brand |
Size |
Price |
|
Antiviral Peptides Library |
L-016 |
|
|
phoenix pep |
85 peptides |
RMB
81618 |
|
APP 17mer peptide / APP770 (204-220) (Human) |
018-74 |
|
|
phoenix pep |
100 μg |
RMB
1519 |
|
DILP 3 Des-Leu1 A-Chain (A28/B25) (Drosophila melanogaster) |
036-73 |
|
|
phoenix pep |
100 μg |
RMB
6054 |
|
EK1 / Pan-HCoV S Inhibitor - Cy5 Labeled |
FC5-071-52 |
|
|
phoenix pep |
1nmol |
RMB
10374 |
|
HR 1-18, HRNR / Hornerin (2656-2677) (Human) |
072-67 |
|
|
phoenix pep |
100 μg |
RMB
3051 |
|
MIEF-1 microprotein / altMiD51 / SMCR7L (Human) |
037-72 |
|
|
phoenix pep |
100 μg |
RMB
4997 |
|
Pal-GR13 |
072-68 |
|
|
phoenix pep |
100 μg |
RMB
4060 |
|
SARS-CoV-2 Omicron BA.4 & BA.5 RBM |
071-80 |
|
|
phoenix pep |
100 μg |
RMB
6125 |
|
TCAP-4 / Teneurin C-terminal Associated Peptide-4 (Human) |
020-22 |
|
|
phoenix pep |
100 μg |
RMB
3561 |
|
α-Helical CRF (12-41) [Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 (MW: 3497.08)] |
SP-89540-1 |
|
|
ADI |
1 mg |
RMB
2284 |
|
α-Helical CRF (9-41) [Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 (MW: 3826.44)] |
SP-89539-1 |
|
|
ADI |
1 mg |
RMB
2284 |
|
β-ANP (Human) |
005-14 |
|
|
phoenix pep |
100 μg |
RMB
6172 |
|
(±) 4’-Hydroxymephenytoin |
X21 |
|
|
oxfordbiomed |
5 mg |
RMB
2224 |
|
(±)-1,4-Diazabicyclo[4.4.0]decane |
AS-29301 |
|
|
Anaspec |
1 g |
Inquiry |
|
(1R,2R)-Boc-2-aminocyclopentane carboxylic acid |
AS-53139-B025 |
|
|
Anaspec |
250 mg |
Inquiry |
|
(1R,2R)-Boc-2-aminocyclopentane carboxylic acid |
AS-53139-B1 |
|
|
Anaspec |
1 g |
Inquiry |
|
(1R,2R)-Fmoc-2-aminocyclopentane carboxylic acid |
AS-53139-F025 |
|
|
Anaspec |
250 mg |
Inquiry |
|
(1R,2R)-Fmoc-2-aminocyclopentane carboxylic acid |
AS-53139-F1 |
|
|
Anaspec |
1 g |
Inquiry |
|
(1R,2S)-Boc-2-aminocyclohexane carboxylic acid |
AS-53131-B025 |
|
|
Anaspec |
250 mg |
Inquiry |
|
(1R,2S)-Boc-2-aminocyclohexane carboxylic acid |
AS-53131-B1 |
|
|
Anaspec |
1 g |
Inquiry |
|
(1R,2S)-Fmoc-2-aminocyclohexane carboxylic acid |
AS-53131-F025 |
|
|
Anaspec |
250 mg |
Inquiry |
|
(1R,2S)-Fmoc-2-aminocyclohexane carboxylic acid |
AS-53131-F1 |
|
|
Anaspec |
1 g |
Inquiry |
|
(1R,3S)-Fmoc-3-aminocyclopentane-1 carboxylic acid |
AS-53143-F025 |
|
|
Anaspec |
250 mg |
Inquiry |
|
(1R,3S)-Fmoc-3-aminocyclopentane-1 carboxylic acid |
AS-53143-F1 |
|
|
Anaspec |
1 g |
Inquiry |
|
(1S,2R)-Boc-2-amino-1-cyclopentanecarboxylic acid |
AS-53138-B005 |
|
|
Anaspec |
50 mg |
Inquiry |
|
|
|
|
|